{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:46:04Z","timestamp":1774608364262,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05802-2","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:35:34Z","timestamp":1751888134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"James B.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Folkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parthiv","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Ezekekwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Hamstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"3","key":"5802_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/bju.15821","volume":"131","author":"M Harvey","year":"2023","unstructured":"Harvey M, Ong WL, Chao M, Udovicich C, McBride S, Bolton D et al (2023) Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer. BJU Int 131(3):280\u2013287","journal-title":"BJU Int"},{"issue":"4","key":"5802_CR2","doi-asserted-by":"publisher","first-page":"EVIDoa2300018","DOI":"10.1056\/EVIDoa2300018","volume":"2","author":"JL Donovan","year":"2023","unstructured":"Donovan JL, Hamdy FC, Lane JA, Young GJ, Metcalfe C, Walsh EI et al (2023) Patient-reported outcomes 12 years after localized prostate cancer treatment. NEJM Evid 2(4):EVIDoa2300018. https:\/\/doi.org\/10.1056\/EVIDoa2300018","journal-title":"NEJM Evid"},{"issue":"4","key":"5802_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41443-020-00389-1","volume":"33","author":"D-D Nguyen","year":"2021","unstructured":"Nguyen D-D, Berlin A, Matthew AG, Perlis N, Elterman DS (2021) Sexual function and rehabilitation after radiation therapy for prostate cancer: a review. Int J Impot Res 33(4):410\u2013417. https:\/\/doi.org\/10.1038\/s41443-020-00389-1","journal-title":"Int J Impot Res"},{"issue":"12","key":"5802_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa074311","volume":"358","author":"MG Sanda","year":"2008","unstructured":"Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250\u20131261. https:\/\/doi.org\/10.1056\/NEJMoa074311","journal-title":"N Engl J Med"},{"issue":"10","key":"5802_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1046\/j.1365-2036.2003.01760.x","volume":"18","author":"B Gami","year":"2003","unstructured":"Gami B, Harrington K, Blake P (2003) How patients manage gastrointestinal symptoms after pelvic radiotherapy: gastronomical symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 18(10):987\u2013994. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01760.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"5802_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00384-012-1593-5","volume":"28","author":"R Krol","year":"2013","unstructured":"Krol R, Smeenk RJ, van Lin ENJT, Hopman WPM (2013) Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy. Int J Colorectal Dis 28(4):519\u2013526. https:\/\/doi.org\/10.1007\/s00384-012-1593-5","journal-title":"Int J Colorectal Dis"},{"key":"5802_CR7","doi-asserted-by":"publisher","unstructured":"Biran A, Bolnykh I, Rimmer B, Cunliffe A, Durrant L, Hancock J et al (2023) A systematic review of population-based studies of chronic bowel symptoms in cancer survivors following pelvic radiotherapy. Cancers (Basel) 15(16). https:\/\/doi.org\/10.3390\/cancers15164037","DOI":"10.3390\/cancers15164037"},{"issue":"2","key":"5802_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3978\/j.issn.2223-4683.2014.04.01","volume":"3","author":"D Liberman","year":"2014","unstructured":"Liberman D, Mehus B, Elliott SP (2014) Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol 3(2):186\u2013195. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2014.04.01","journal-title":"Transl Androl Urol"},{"issue":"10","key":"5802_CR9","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","volume":"294","author":"AL Zietman","year":"2005","unstructured":"Zietman AL, Desilvio ML, Slater JD (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294(10):1233\u20131239. https:\/\/doi.org\/10.1001\/jama.294.10.1233","journal-title":"JAMA"},{"issue":"2","key":"5802_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1200\/JCO.1999.17.2.517","volume":"17","author":"MJ Zelefsky","year":"1999","unstructured":"Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T et al (1999) Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17(2):517\u2013522. https:\/\/doi.org\/10.1200\/JCO.1999.17.2.517","journal-title":"J Clin Oncol"},{"issue":"11","key":"5802_CR11","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/(sici)1097-0142(19990601)85:11<2460::aid-cncr23>3.0.co;2-n","volume":"85","author":"MJ Zelefsky","year":"1999","unstructured":"Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A et al (1999) Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85(11):2460\u20132468. 10.1002\/(sici)1097-0142(19990601)85:11<2460::aid-cncr23>3.0.co;2-n","journal-title":"Cancer"},{"issue":"4","key":"5802_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0360-3016(91)90732-j","volume":"21","author":"CA Lawton","year":"1991","unstructured":"Lawton CA, Won M, Pilepich MV, Asbell SO, Shipley WU, Hanks GE et al (1991) Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21(4):935\u2013939. https:\/\/doi.org\/10.1016\/0360-3016(91)90732-j","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"5802_CR13","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00345-020-03414-6","volume":"39","author":"S Vaggers","year":"2021","unstructured":"Vaggers S, Rai BP, Chedgy ECP, de la Taille A, Somani BK (2021) Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique. World J Urol 39(6):1769\u20131780. https:\/\/doi.org\/10.1007\/s00345-020-03414-6","journal-title":"World J Urol"},{"issue":"4","key":"5802_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaoncol.2022.7592","volume":"9","author":"NF Mariados","year":"2023","unstructured":"Mariados NF, Orio PF, Schiffman Z, Van TJ, Engelman A, Nurani R et al (2023) Hyaluronic acid spacer for hypofractionated prostate radiation therapy: a randomized clinical trial. JAMA Oncol 9(4):511\u2013518. https:\/\/doi.org\/10.1001\/jamaoncol.2022.7592","journal-title":"JAMA Oncol"},{"issue":"5","key":"5802_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.ijrobp.2024.07.2145","volume":"120","author":"D Song","year":"2024","unstructured":"Song D, Dabkowski M, Costa P, Nurani R, Kos M, Vanneste B et al (2024) Prospective, randomized controlled pivotal trial of biodegradable balloon rectal spacer for prostate radiation therapy. Int J Radiat Oncol Biol Phys 120(5):1410\u20131420. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.07.2145","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5802_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.urology.2017.11.016","volume":"115","author":"LI Karsh","year":"2018","unstructured":"Karsh LI, Gross ET, Pieczonka CM, Aliotta PJ, Skomra CJ, Ponsky LE et al (2018) Absorbable hydrogel spacer use in prostate radiotherapy: a comprehensive review of phase 3 clinical trial published data. Urology 115:39\u201344. https:\/\/doi.org\/10.1016\/j.urology.2017.11.016","journal-title":"Urology"},{"key":"5802_CR17","doi-asserted-by":"publisher","unstructured":"Miller LE, Efstathiou JA, Bhattacharyya SK, Payne HA, Woodward E, Pinkawa M (2020) Association of the placement of a perirectal hydrogel spacer with the clinical outcomes of men receiving radiotherapy for prostate cancer: a systematic review and meta-analysis. JAMA Netw Open 3(6). https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.8221","DOI":"10.1001\/jamanetworkopen.2020.8221"},{"issue":"2","key":"5802_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijrobp.2017.05.035","volume":"99","author":"M Pinkawa","year":"2017","unstructured":"Pinkawa M, Berneking V, Schlenter M, Krenkel B, Eble MJ (2017) Quality of life after radiation therapy for prostate cancer with a hydrogel spacer: 5-year results. Int J Radiat Oncol Biol Phys 99(2):374\u2013377. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5802_CR19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","volume":"97","author":"DA Hamstra","year":"2017","unstructured":"Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R et al (2017) Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial. Int J Radiat Oncol Biol Phys 97(5):976\u2013985. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.12.024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5802_CR20","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.prro.2017.07.008","volume":"8","author":"DA Hamstra","year":"2018","unstructured":"Hamstra DA, Mariados N, Sylvester J, Shah D, Gross E, Hudes R et al (2018) Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal\/prostate spacer: secondary analysis of a phase 3 trial. Pract Radiat Oncol 8(1):e7\u201315. https:\/\/doi.org\/10.1016\/j.prro.2017.07.008","journal-title":"Pract Radiat Oncol"},{"key":"5802_CR21","doi-asserted-by":"publisher","first-page":"1239104","DOI":"10.3389\/fonc.2023.1239104","volume":"13","author":"ZA Seymour","year":"2023","unstructured":"Seymour ZA, Pinkawa M, Daignault-Newton S, Bosch W, Michalski JM, Gay H et al (2023) A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. Front Oncol 13:1239104. https:\/\/doi.org\/10.3389\/fonc.2023.1239104","journal-title":"Front Oncol"},{"issue":"3","key":"5802_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/bju.15097","volume":"126","author":"ZA Seymour","year":"2020","unstructured":"Seymour ZA, Hamstra DA, Daignault-Newton S, Bosch W, Michalski J, Gay HA et al (2020) Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life: rectal spacer and bowel-associated QOL after RT. BJU Int 126(3):367\u2013372. https:\/\/doi.org\/10.1111\/bju.15097","journal-title":"BJU Int"},{"key":"5802_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/POR.S89946","volume":"6","author":"F Porzsolt","year":"2015","unstructured":"Porzsolt F, Rocha NG, Toledo-Arruda AC, Thomaz TG, Moraes C, Bessa-Guerra TR et al (2015) Efficacy and effectiveness trials have different goals, use different tools, and generate different messages. Pragmat Obs Res 6:47\u201354. https:\/\/doi.org\/10.2147\/POR.S89946","journal-title":"Pragmat Obs Res"},{"key":"5802_CR24","unstructured":"Standard Analytical Files (Medicare Claims) - LDS| CMS. www.cms.gov. (Updated 2024). https:\/\/www.cms.gov\/data-research\/files-for-order\/limited-data-set-lds-files\/standard-analytical-files-medicare-claims-lds. Accessed 31 Oct 2024"},{"key":"5802_CR25","unstructured":"Social Determinants of Health (SDOH)| Agency for Healthcare Research and Quality. www.ahrq.gov.2023. (Updated 2024). https:\/\/www.ahrq.gov\/sdoh\/index.html. Accessed Oct 2024"},{"issue":"18","key":"5802_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1200\/jco.2017.75.5371","volume":"36","author":"HY Pan","year":"2018","unstructured":"Pan HY, Jiang J, Hoffman KE, Tang C, Choi SL, Nguyen QN et al (2018) Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer. J Clin Oncol 36(18):1823\u20131830. https:\/\/doi.org\/10.1200\/jco.2017.75.5371","journal-title":"J Clin Oncol"},{"key":"5802_CR27","unstructured":"Hamstra DA (2023) Available Rectal Spacer Options for Patients with Prostate Cancer Undergoing Radiation Therapy. Urology Times. http:\/\/www.urologytimes.com\/view\/available-rectal-spacer-options-for-patients-with-prostate-cancer-undergoing-radiation-therapy. Accessed 24 Oct"},{"key":"5802_CR28","unstructured":"American Cancer Society (2024) Key statistics for prostate Cancer| prostate Cancer facts. Www.cancer.org. Am Cancer Soc. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05802-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05802-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05802-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:02:49Z","timestamp":1767996169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05802-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5802"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05802-2","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ryoko Sato, Samir Bhattacharyya, and Emmanuel Ezekekwu are employees of Boston Scientific. James Yu reports consulting fees from Boston Scientific, Teleflex, and AlphaSights, research support from Pfizer\/Myovant\/Sumitomo Pharma, and is a stockholder of Modifi Bio. Michael Folkert has received travel reimbursement from Varian and Boston Scientific, and his affiliated institutions have received funding for clinical trials from Boston Scientific. Ryan Hankins is a clinical consultant for Boston Scientific. Sean Collins is a consultant for Boston Scientific. Daniel Hamstra is a paid consultant for Boston Scientific.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was exempt from Institutional Review Board (IRB) approval as this research project used data from an anonymous, de-identified, medical clearinghouse administrative claims database compliant with the Health Insurance Portability and Accountability Act of 1996.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"417"}}